LenaRic: A phase II study of adjuvant use of lenalidomide in patients undergoing reduced intensity condtioning allogenic transplantation for multiple myeloma

Project Details

Short titleLenaRic: A phase II study of adjuvant use of lenalidomide in patients undergoing reduced intensity condtioning allogenic transplantation for multiple myeloma
StatusFinished
Effective start/end date1/04/1131/12/21

Funding

  • Cancer Research Uk
  • Uhb Nhs Trust